Biblio

Export 157 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
K. M. Hawkins and Sergio, L. E., “Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1161-72, 2016.
G. Hautecloque-Raysz, Sellal, F., Bousiges, O., Phillipi, N., Blanc, F., and Cretin, B., “Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
Y. Hattori, Maki, T., Saito, S., Yamamoto, Y., Nagatsuka, K., and Ihara, M., “Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1037-45, 2016.
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M., “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
M. Hashimoto, Ho, G., Sugama, S., Takamatsu, Y., Shimizu, Y., Takenouchi, T., Waragai, M., and Masliah, E., “Evolvability of Amyloidogenic Proteins in Human Brain.”, J Alzheimers Dis, vol. 62, no. 1, pp. 73-83, 2018.
M. Hashimoto, Ho, G., Sugama, S., Takenouchi, T., Waragai, M., Sugino, H., Inoue, S., and Masliah, E., “Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.”, J Alzheimers Dis, vol. 81, no. 2, pp. 451-458, 2021.
M. Hashimoto, Yamazaki, A., Ohno, A., Kimura, T., Winblad, B., and Tjernberg, L. O., “A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1163-1174, 2019.
Y. Hasegawa, Toyama, K., Uekawa, K., Ichijo, H., and Kim-Mitsuyama, S., “Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
K. N. Hascup and Hascup, E. R., “Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine Receptor.”, J Alzheimers Dis, vol. 53, no. 1, pp. 337-47, 2016.
J. Hartmann, Roßmeier, C., Riedl, L., Dorn, B., Fischer, J., Slawik, T., Fleischhaker, M., Hartmann, F., Egert-Schwender, S., Kehl, V., Haller, B., Schneider-Schelte, H., Dinkel, A., Jox, R. J., and Diehl-Schmid, J., “Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset.”, J Alzheimers Dis, vol. 80, no. 1, pp. 283-297, 2021.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., “Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.”, J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
J. R. Harrison, Mistry, S., Muskett, N., and Escott-Price, V., “From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1271-1283, 2020.
K. Harris, Ling, Y., Bukhbinder, A. S., Chen, L., Phelps, K. N., Cruz, G., Thomas, J., Kim, Y., Jiang, X., and Schulz, P. E., “The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching.”, J Alzheimers Dis, vol. 95, no. 2, pp. 703-718, 2023.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., “VEGFR1 and VEGFR2 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
K. Hares, Miners, J. Scott, Cook, A. Jane, Rice, C., Scolding, N., Love, S., and Wilkins, A., “Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1511-1524, 2017.
C. J. D. Hardy, Buckley, A. H., Downey, L. E., Lehmann, M., Zimmerer, V. C., Varley, R. A., Crutch, S. J., Rohrer, J. D., Warrington, E. K., and Warren, J. D., “The Language Profile of Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 50, no. 2, pp. 359-71, 2016.
A. Harding, Robinson, S., Crean, S. J., and Singhrao, S. K., “Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?”, J Alzheimers Dis, vol. 58, no. 2, pp. 337-348, 2017.
A. A. Harb, Chen, R. J., Chase, H. S., Natarajan, K., and Noble, J. M., “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
H. Hara, Ono, F., Nakamura, S., Matsumoto, S. - E., Jin, H., Hattori, N., and Tabira, T., “An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1047-1059, 2016.
M. Happich, Kirson, N. Y., Desai, U., King, S., Birnbaum, H. G., Reed, C., Belger, M., Lenox-Smith, A., and Price, D., “Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 171-83, 2016.
L. Hao, Wang, X., Zhang, L., Xing, Y., Guo, Q., Hu, X., Mu, B., Chen, Y., Chen, G., Cao, J., Zhi, X., Liu, J., Li, X., Yang, L., Li, J., Du, W., Sun, Y., Wang, T., Liu, Z., Liu, Z., Zhao, X., Li, H., Yu, Y., Wang, X., Jia, J., and Han, Y., “Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population.”, J Alzheimers Dis, vol. 60, no. 2, pp. 371-388, 2017.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., “Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
H. H. Hansen, Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. Bjerre, Farr, S. A., and Vrang, N., “The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, 2015.

Pages